Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAthelney Tst. Regulatory News (ATY)

Share Price Information for Athelney Tst. (ATY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 177.50
Bid: 165.00
Ask: 190.00
Change: 0.00 (0.00%)
Spread: 25.00 (15.152%)
Open: 177.50
High: 177.50
Low: 177.50
Prev. Close: 177.50
ATY Live PriceLast checked at -
Athelney is an Investment Trust

To provide shareholders with prospects of long term capital growth by investing in companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

3 Sep 2020 10:49

RNS Number : 9670X
Athelney Trust PLC
03 September 2020
 

Athelney Trust PLC

 

Legal Entity Identifier:

213800ON67TJC7F4DL05

The unaudited net asset value of Athelney Trust was 235.4p at 31 August 2020.

Fund Manager's comment for August 2020

In last month's commentary we noted that besides the fact that global GDP had contracted in the second quarter as a result of COVID-19, the worst appeared to be over. This was confirmed in recent data releases which indicated that while Europe's August PMI surveys were mixed, those for the U.K. had firmed, including being the strongest reading for the Services PMI since 2013. However, in an economy responding to targeted stimuli by the Government, this can be misleading and mask underlying structural issues and competitive pressures on the profitability of some businesses.

 

We continued to realign the portfolio by selling out of our position in Costain, having recently added YouGov and Clinigen into the portfolio. YouGov is an international research and data analytics group headquartered in London which collects and stores data from a proprietary global panel of over 8 million people on consumer opinions, attitudes and behaviour every day. This data is then analysed and used to provide insights that enable intelligent decision-making and improves a wide spectrum of marketing activities for a customer-base which includes media owners, brands and media agencies.

 

Clinigen Group plc is a global business with supply and distribution hubs in key long-term growth regions on five continents and in 14 countries. It is focused on providing ethical access to medicines in the three areas of; global medicine supply; clinical trial, unlicensed and licensed medicines.

During the past month the MSCI World Index and the S&P 500 were up by 6.5% and 7.1% in US$ respectively, driven by the continued rise in the large tech stocks and the FAANGS in particular. The UK market under-performed the global indices with those UK indices associated with smaller companies faring much better as has been the case in recent months. The FTSE 100 was up by 0.5%, the Small Cap Index was up by 3.4%, while the Fledgling Index was up by 3.7% for the month and the AIM All Share Index produced an amazing performance, increasing by 8.9%.

While our overall performance was dragged down by our 29% exposure to property, we are nevertheless pleased with the overall performance of our portfolio which was up by 2.8% during the month. After providing for the company expenses the net performance as reflected in the NAV was an increase of 2.7%.

Cash was conserved to pay the dividend, comprising 4.6% of the portfolio at month end.

 

Fact Sheet

An accompanying fact sheet which includes the information above as well as wider details on the portfolio can be found on the Fund's website www.athelneytrust.co.uk under "About">"Latest Monthly Fact Sheet"

Background Information

Dr. Emmanuel (Manny) Pohl AM

Manny is Chairman and Chief Investment Officer of E C Pohl & Co ("ECP"), an investment management company and has been a major shareholder in Athelney trust for many years.

E C Pohl & co is licensed by the Australian Financial services (licence no.421704).

www.ecpohl.com

www.ecpam.com

Manny Pohl and the ECP group has over AU$1500m under its management including four listed investment companies, three listed in Australia and one in the UK:

· Flagship Investments (ASX code:FSI)

AUD50m https://flagshipinvestments.com.au

· Barrack St Investments (ASX code: BST)

AUD25m www.barrackst.com

· Global Masters Fund Limited (ASX code: GFL)

AUD25m www.globalmastersfund.com.au

· Athelney Trust plc (LSE code: ATY)

GBP5m www.athelneytrust.co.uk

Athelney Trust plc Investment Policy

 The investment objective of the Trust is to provide shareholders with prospects of long-term capital growth with the risks inherent in small cap investment minimised through a spread of holdings in quality small cap companies that operate in various industries and sectors. The Fund Manager also considers that it is important to maintain a progressive dividend record.

The assets of the Trust are allocated predominantly to companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX. The assets of the Trust have been allocated in two main ways: first, to the shares of those companies which have grown steadily over the years in terms of profits and dividends but, despite this progress, the market rating is favourable when compared to future earnings and dividends; second, to those companies whose shares are standing at a favourable level compared with the value of land, buildings or cash in the balance sheet.

Athelney Trust was founded in 1994. In 1996 it was one of the ten pioneer members of the Alternative Investment Market ("AIM"). In 2008 the shares became fully listed on the main market of the London Stock Exchange. Athelney Trust has a successful progressive dividend growth record and the dividend has grown every year since 2004. According to the Association of Investment Companies (AIC) Athelney Trust is one of only "22 investment companies that have increased their dividend every year between 10 and 20 years - the next generation of dividend heroes" (as at 23/03/20). See link

www.theaic.co.uk/aic/news/press-releases/the-next-generation-of-dividend-heroes

Website

www.athelneytrust.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVGCGDCCSGDGGX
Date   Source Headline
15th Apr 20197:00 amRNSDirectorate Change
5th Apr 201911:16 amRNSNet Asset Value(s)
4th Apr 20197:52 amRNSResult of AGM
29th Mar 20199:20 amRNSHolding(s) in Company
27th Mar 20194:12 pmRNSAmendment to the Chairmans letter re Notice of AGM
20th Mar 20197:00 amRNSBoard Letter to Shareholders
18th Mar 20199:05 amRNSLetter to Shareholders
14th Mar 20198:59 amRNSHolding(s) in Company
6th Mar 20191:52 pmRNSAnnual Financial Report - Amendment
5th Mar 20198:29 amRNSAnnual Financial Report
4th Mar 201912:12 pmRNSNet Asset Value(s)
11th Feb 20197:00 amRNSDirectorate Change
6th Feb 201910:30 amRNSNet Asset Value(s)
25th Jan 20191:37 pmRNSDirectorate Change
25th Jan 201910:08 amRNSDirectorate Change
22nd Jan 20192:52 pmRNSResult of EGM
11th Jan 20193:00 pmRNSEGM Shareholder Statement
4th Jan 201910:26 amRNSNet Asset Value(s)
28th Dec 20184:00 pmRNSNotice of Extraordinary General Meeting
19th Dec 20181:43 pmRNSDirector/PDMR Shareholding
19th Dec 20189:09 amRNSDirector/PDMR Shareholding
17th Dec 201811:28 amRNSStatement re Corporate Action
5th Dec 201810:43 amRNSNet Asset Value(s)
3rd Dec 20189:38 amRNSDirectorate Change
5th Nov 20189:39 amRNSNet Asset Value(s)
3rd Oct 20183:20 pmRNSNet Asset Value(s)
1st Oct 201811:43 amRNSDirectorate Change
5th Sep 201810:54 amRNSNet Asset Value(s)
3rd Aug 20188:30 amRNSNet Asset Value(s)
20th Jul 20187:00 amRNSHalf-year Report
4th Jul 20189:48 amRNSNet Asset Value(s)
25th Jun 20189:15 amRNSChange of Adviser
4th Jun 201812:52 pmRNSNet Asset Value(s)
2nd May 20182:12 pmRNSNet Asset Value(s)
30th Apr 20182:03 pmRNSDirectorate Change
16th Apr 20188:54 amRNSDirector/PDMR Shareholding
9th Apr 201811:35 amRNSNet Asset Value(s)
22nd Mar 201810:14 amRNSAGM Statement
6th Mar 201812:50 pmRNSNet Asset Value(s)
16th Feb 20187:00 amRNSAnnual Financial Report
6th Feb 20189:05 amRNSNet Asset Value(s)
3rd Jan 201810:51 amRNSNet Asset Value(s)
5th Dec 201710:15 amRNSNet Asset Value(s)
2nd Nov 201712:52 pmRNSNet Asset Value(s)
3rd Oct 201711:24 amRNSNet Asset Value(s)
4th Sep 201712:00 pmRNSNet Asset Value(s)
3rd Aug 20178:34 amRNSNet Asset Value(s)
25th Jul 20177:00 amRNSHalf-year Report
5th Jul 201710:59 amRNSNet Asset Value(s)
5th Jul 20179:53 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.